Cover Image
Market Research Report

Global Biosimilar Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

Published by QYResearch Product code 715047
Published Content info 125 Pages
Delivery time: 3-5 business days
Price
Back to Top
Global Biosimilar Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
Published: October 1, 2018 Content info: 125 Pages
Description

In 2018, the global Biosimilar Monoclonal Antibodies market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Biosimilar Monoclonal Antibodies.

This study researches the market size of Biosimilar Monoclonal Antibodies, presents the global Biosimilar Monoclonal Antibodies sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Biosimilar Monoclonal Antibodies in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Biosimilar Monoclonal Antibodies for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.

  • ProMab Biotechnologies
  • Allergan plc
  • Abbott
  • BioXpress Therapeutics
  • Bayer
  • Bio Farma
  • Merck
  • Therapeutics
  • Biocon
  • Boehringer Ingelheim
  • Celltrion Inc.
  • Coherus BioSciences Inc.
  • Zydus-Cadila
  • Genor BioPharma
  • Intas Pharmaceuticals
  • Novartis
  • Pfizer
  • Reliance Life Sciences

Market Segment by Product Type

  • Infliximab
  • Rituximab
  • Abciximab
  • Trastuzumab
  • Adalimumab
  • Bevacizumab

Market Segment by Application

  • Oncology
  • Chronic and Autoimmune Diseases
  • Growth Hormone Deficiency
  • Infectious Diseases
  • Others

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Biosimilar Monoclonal Antibodies status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Biosimilar Monoclonal Antibodies manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biosimilar Monoclonal Antibodies are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
Table of Contents

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
    • 1.3.1. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type
    • 1.3.2. Infliximab
    • 1.3.3. Rituximab
    • 1.3.4. Abciximab
    • 1.3.5. Trastuzumab
    • 1.3.6. Adalimumab
    • 1.3.7. Bevacizumab
  • 1.4. Market Segment by Application
    • 1.4.1. Global Biosimilar Monoclonal Antibodies Market Share by Application (2018-2025)
    • 1.4.2. Oncology
    • 1.4.3. Chronic and Autoimmune Diseases
    • 1.4.4. Growth Hormone Deficiency
    • 1.4.5. Infectious Diseases
    • 1.4.6. Others
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Biosimilar Monoclonal Antibodies Market Size
    • 2.1.1. Global Biosimilar Monoclonal Antibodies Revenue 2013-2025
    • 2.1.2. Global Biosimilar Monoclonal Antibodies Sales 2013-2025
  • 2.2. Biosimilar Monoclonal Antibodies Growth Rate by Regions
    • 2.2.1. Global Biosimilar Monoclonal Antibodies Sales by Regions 2013-2018
    • 2.2.2. Global Biosimilar Monoclonal Antibodies Revenue by Regions 2013-2018
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Biosimilar Monoclonal Antibodies Sales by Manufacturers
    • 3.1.1. Biosimilar Monoclonal Antibodies Sales by Manufacturers 2013-2018
    • 3.1.2. Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers 2013-2018
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2013-2018)
    • 3.2.2. Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2013-2018)
    • 3.2.3. Global Biosimilar Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
  • 3.3. Biosimilar Monoclonal Antibodies Price by Manufacturers
  • 3.4. Key Manufacturers Biosimilar Monoclonal Antibodies Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
  • 3.6. Key Manufacturers Biosimilar Monoclonal Antibodies Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Sales and Revenue for Each Type
    • 4.1.1. Infliximab Sales and Revenue (2013-2018)
    • 4.1.2. Rituximab Sales and Revenue (2013-2018)
    • 4.1.3. Abciximab Sales and Revenue (2013-2018)
    • 4.1.4. Trastuzumab Sales and Revenue (2013-2018)
    • 4.1.5. Adalimumab Sales and Revenue (2013-2018)
    • 4.1.6. Bevacizumab Sales and Revenue (2013-2018)
  • 4.2. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type
  • 4.3. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type
  • 4.4. Biosimilar Monoclonal Antibodies Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Biosimilar Monoclonal Antibodies Sales by Application

6. North America

  • 6.1. North America Biosimilar Monoclonal Antibodies Breakdown Data by Company
  • 6.2. North America Biosimilar Monoclonal Antibodies Breakdown Data by Type
  • 6.3. North America Biosimilar Monoclonal Antibodies Breakdown Data by Application
  • 6.4. North America Biosimilar Monoclonal Antibodies Breakdown Data by Countries
    • 6.4.1. North America Biosimilar Monoclonal Antibodies Sales by Countries
    • 6.4.2. North America Biosimilar Monoclonal Antibodies Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe Biosimilar Monoclonal Antibodies Breakdown Data by Company
  • 7.2. Europe Biosimilar Monoclonal Antibodies Breakdown Data by Type
  • 7.3. Europe Biosimilar Monoclonal Antibodies Breakdown Data by Application
  • 7.4. Europe Biosimilar Monoclonal Antibodies Breakdown Data by Countries
    • 7.4.1. Europe Biosimilar Monoclonal Antibodies Sales by Countries
    • 7.4.2. Europe Biosimilar Monoclonal Antibodies Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Biosimilar Monoclonal Antibodies Breakdown Data by Company
  • 8.2. Asia Pacific Biosimilar Monoclonal Antibodies Breakdown Data by Type
  • 8.3. Asia Pacific Biosimilar Monoclonal Antibodies Breakdown Data by Application
  • 8.4. Asia Pacific Biosimilar Monoclonal Antibodies Breakdown Data by Countries
    • 8.4.1. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Countries
    • 8.4.2. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America Biosimilar Monoclonal Antibodies Breakdown Data by Company
  • 9.2. Central & South America Biosimilar Monoclonal Antibodies Breakdown Data by Type
  • 9.3. Central & South America Biosimilar Monoclonal Antibodies Breakdown Data by Application
  • 9.4. Central & South America Biosimilar Monoclonal Antibodies Breakdown Data by Countries
    • 9.4.1. Central & South America Biosimilar Monoclonal Antibodies Sales by Countries
    • 9.4.2. Central & South America Biosimilar Monoclonal Antibodies Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa Biosimilar Monoclonal Antibodies Breakdown Data by Type
  • 10.2. Middle East and Africa Biosimilar Monoclonal Antibodies Breakdown Data by Application
  • 10.3. Middle East and Africa Biosimilar Monoclonal Antibodies Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries
    • 10.3.2. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. ProMab Biotechnologies
    • 11.1.1. ProMab Biotechnologies Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.1.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.1.5. ProMab Biotechnologies Recent Development
  • 11.2. Allergan plc
    • 11.2.1. Allergan plc Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.2.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.2.5. Allergan plc Recent Development
  • 11.3. Abbott
    • 11.3.1. Abbott Company Details
    • 11.3.2. Company Description and Business Overview
    • 11.3.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.3.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.3.5. Abbott Recent Development
  • 11.4. BioXpress Therapeutics
    • 11.4.1. BioXpress Therapeutics Company Details
    • 11.4.2. Company Description and Business Overview
    • 11.4.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.4.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.4.5. BioXpress Therapeutics Recent Development
  • 11.5. Bayer
    • 11.5.1. Bayer Company Details
    • 11.5.2. Company Description and Business Overview
    • 11.5.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.5.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.5.5. Bayer Recent Development
  • 11.6. Bio Farma
    • 11.6.1. Bio Farma Company Details
    • 11.6.2. Company Description and Business Overview
    • 11.6.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.6.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.6.5. Bio Farma Recent Development
  • 11.7. Merck
    • 11.7.1. Merck Company Details
    • 11.7.2. Company Description and Business Overview
    • 11.7.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.7.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.7.5. Merck Recent Development
  • 11.8. Therapeutics
    • 11.8.1. Therapeutics Company Details
    • 11.8.2. Company Description and Business Overview
    • 11.8.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.8.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.8.5. Therapeutics Recent Development
  • 11.9. Biocon
    • 11.9.1. Biocon Company Details
    • 11.9.2. Company Description and Business Overview
    • 11.9.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.9.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.9.5. Biocon Recent Development
  • 11.10. Boehringer Ingelheim
    • 11.10.1. Boehringer Ingelheim Company Details
    • 11.10.2. Company Description and Business Overview
    • 11.10.3. Sales, Revenue and Market Share of Biosimilar Monoclonal Antibodies
    • 11.10.4. Biosimilar Monoclonal Antibodies Product Introduction
    • 11.10.5. Boehringer Ingelheim Recent Development
  • 11.11. Celltrion Inc.
  • 11.12. Coherus BioSciences Inc.
  • 11.13. Zydus-Cadila
  • 11.14. Genor BioPharma
  • 11.15. Intas Pharmaceuticals
  • 11.16. Novartis
  • 11.17. Pfizer
  • 11.18. Reliance Life Sciences

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Biosimilar Monoclonal Antibodies Sales Channels
    • 12.2.2. Biosimilar Monoclonal Antibodies Distributors
  • 12.3. Biosimilar Monoclonal Antibodies Customers

13. Market Forecast

  • 13.1. Global Biosimilar Monoclonal Antibodies Sales and Revenue Forecast 2018-2025
  • 13.2. Global Biosimilar Monoclonal Antibodies Sales Forecast by Type
  • 13.3. Global Biosimilar Monoclonal Antibodies Sales Forecast by Application
  • 13.4. Biosimilar Monoclonal Antibodies Forecast by Regions
    • 13.4.1. Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2018-2025
    • 13.4.2. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2018-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America Biosimilar Monoclonal Antibodies Forecast by Countries 2018-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe Biosimilar Monoclonal Antibodies Forecast by Countries 2018-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific Biosimilar Monoclonal Antibodies Sales Forecast by Countries 2018-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America Biosimilar Monoclonal Antibodies Sales Forecast by Countries 2018-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Forecast by Countries 2018-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer

List of Tables and Figures

  • Figure Biosimilar Monoclonal Antibodies Product Picture
  • Table Biosimilar Monoclonal Antibodies Key Market Segments
  • Table Major Manufacturers Biosimilar Monoclonal Antibodies Covered in This Report
  • Table Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Shar by Type 2013-2025
  • Figure Infliximab Figures
  • Table Major Manufacturers of Infliximab
  • Figure Rituximab Figures
  • Table Major Manufacturers of Rituximab
  • Figure Abciximab Figures
  • Table Major Manufacturers of Abciximab
  • Figure Trastuzumab Figures
  • Table Major Manufacturers of Trastuzumab
  • Figure Adalimumab Figures
  • Table Major Manufacturers of Adalimumab
  • Figure Bevacizumab Figures
  • Table Major Manufacturers of Bevacizumab
  • Table Global Biosimilar Monoclonal Antibodies Market Share by Application 2018-2025 (K Units)
  • Figure Oncology Use Case
  • Figure Chronic and Autoimmune Diseases Use Case
  • Figure Growth Hormone Deficiency Use Case
  • Figure Infectious Diseases Use Case
  • Figure Others Use Case
  • Figure Biosimilar Monoclonal Antibodies Report Years Considered
  • Figure Global Biosimilar Monoclonal Antibodies Market Size 2013-2025 (Million US$)
  • Figure Global Biosimilar Monoclonal Antibodies Sales 2013-2018 (K Units)
  • Table Global Biosimilar Monoclonal Antibodies Market Size by Regions 2013-2018 (K Units) & (Million US$)
  • Table Global Biosimilar Monoclonal Antibodies Sales by Regions 2013-2018 (K Units)
  • Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions 2013-2018
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions 2013-2018
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions in 2018
  • Table Global Biosimilar Monoclonal Antibodies Revenue by Regions 2013-2018 (Million US$)
  • Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions 2013-2018
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions 2013-2018
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2013-2018) (K Units)
  • Table Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers in 2018
  • Table Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2013-2018)
  • Figure Biosimilar Monoclonal Antibodies Value Share by Manufacturers in 2018
  • Table Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Biosimilar Monoclonal Antibodies Price (2013-2018) (USD/Unit)
  • Table Key Manufacturers Biosimilar Monoclonal Antibodies Plants/Factories Distribution
  • Table Key Manufacturers Biosimilar Monoclonal Antibodies Area Served
  • Table Date of Key Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
  • Table Key Manufacturers Biosimilar Monoclonal Antibodies Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Infliximab Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Rituximab Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Abciximab Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Trastuzumab Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Adalimumab Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Bevacizumab Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Biosimilar Monoclonal Antibodies Sales by Type (2013-2018) (K Units)
  • Table Global Biosimilar Monoclonal Antibodies Sales Share by Type (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
  • Table Global Biosimilar Monoclonal Antibodies Revenue by Type (2013-2018) (Million US$)
  • Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2017
  • Table Biosimilar Monoclonal Antibodies Price by Type 2013-2018 (USD/Unit)
  • Table Global Biosimilar Monoclonal Antibodies Sales by Application (2013-2018) (K Units)
  • Table Global Biosimilar Monoclonal Antibodies Sales Share by Application (2013-2018)
  • Figure Global Sales Biosimilar Monoclonal Antibodies Market Share by Application (2013-2018)
  • Figure Global Sales Biosimilar Monoclonal Antibodies Market Share by Application in 2017
  • Figure North America Biosimilar Monoclonal Antibodies Sales Growth Rate 2013-2018 (K Units)
  • Figure North America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Biosimilar Monoclonal Antibodies Sales by Company (2013-2018) (K Units)
  • Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Company (2013-2018)
  • Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2018
  • Table North America Biosimilar Monoclonal Antibodies Sales by Type (2013-2018) (K Units)
  • Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure North America Biosimilar Monoclonal Antibodies Market Share by Type in 2018
  • Table North America Biosimilar Monoclonal Antibodies Sales by Application (2013-2018) (K Units)
  • Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
  • Figure North America Biosimilar Monoclonal Antibodies Market Share by Application in 2018
  • Table North America Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018) (K Units)
  • Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries
  • Table North America Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018) (Million US$)
  • Table North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
  • Figure United States Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Canada Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Mexico Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Europe Biosimilar Monoclonal Antibodies Sales Growth Rate 2013-2018 (K Units)
  • Figure Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Biosimilar Monoclonal Antibodies Sales by Company (2013-2018) (K Units)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Company (2013-2018)
  • Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2018
  • Table Europe Biosimilar Monoclonal Antibodies Sales by Type (2013-2018) (K Units)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Biosimilar Monoclonal Antibodies Market Share by Type
  • Table Europe Biosimilar Monoclonal Antibodies Sales by Application (2013-2018) (K Units)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Biosimilar Monoclonal Antibodies Market Share by Application
  • Table Europe Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018) (K Units)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries
  • Table Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
  • Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2018
  • Figure Germany Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure France Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure UK Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Italy Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Russia Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Asia Pacific Biosimilar Monoclonal Antibodies Sales Growth Rate 2013-2018 (K Units)
  • Figure Asia Pacific Biosimilar Monoclonal Antibodies Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by Company (2013-2018) (K Units)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2018
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by Type (2013-2018) (K Units)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Biosimilar Monoclonal Antibodies Market Share by Type in 2018
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by Application (2013-2018) (K Units)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Biosimilar Monoclonal Antibodies Market Share by Application in 2018
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018) (K Units)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
  • Figure China Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure China Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Korea Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure India Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Australia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Indonesia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Malaysia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Philippines Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Thailand Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Vietnam Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Biosimilar Monoclonal Antibodies Sales Growth Rate 2013-2018 (K Units)
  • Figure Central & South America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales by Company (2013-2018) (K Units)
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Company (2013-2018)
  • Figure Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2018
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales by Type (2013-2018) (K Units)
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure Central & South America Biosimilar Monoclonal Antibodies Market Share by Type in 2018
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales by Application (2013-2018) (K Units)
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
  • Figure Central & South America Biosimilar Monoclonal Antibodies Market Share by Application in 2018
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018) (K Units)
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2018
  • Table Central & South America Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2018
  • Figure Brazil Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Brazil Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (K Units)
  • Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales Growth Rate 2013-2018 (K Units)
  • Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type (2013-2018) (K Units)
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Biosimilar Monoclonal Antibodies Market Share by Type
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application (2013-2018) (K Units)
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Biosimilar Monoclonal Antibodies Market Share by Application
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018) (K Units)
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
  • Figure GCC Countries Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure GCC Countries Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (K Units)
  • Figure Egypt Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure Egypt Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (K Units)
  • Figure South Africa Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018) (K Units)
  • Figure South Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate (2013-2018) (K Units)
  • Table ProMab Biotechnologies Company Details
  • Table ProMab Biotechnologies Description and Business Overview
  • Table ProMab Biotechnologies Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table ProMab Biotechnologies Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table ProMab Biotechnologies Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table ProMab Biotechnologies Recent Development
  • Table Allergan plc Company Details
  • Table Allergan plc Description and Business Overview
  • Table Allergan plc Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Allergan plc Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table Allergan plc Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table Allergan plc Recent Development
  • Table Abbott Company Details
  • Table Abbott Description and Business Overview
  • Table Abbott Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Abbott Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table Abbott Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table Abbott Recent Development
  • Table BioXpress Therapeutics Company Details
  • Table BioXpress Therapeutics Description and Business Overview
  • Table BioXpress Therapeutics Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table BioXpress Therapeutics Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table BioXpress Therapeutics Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table BioXpress Therapeutics Recent Development
  • Table Bayer Company Details
  • Table Bayer Description and Business Overview
  • Table Bayer Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Bayer Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table Bayer Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table Bayer Recent Development
  • Table Bio Farma Company Details
  • Table Bio Farma Description and Business Overview
  • Table Bio Farma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Bio Farma Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table Bio Farma Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table Bio Farma Recent Development
  • Table Merck Company Details
  • Table Merck Description and Business Overview
  • Table Merck Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Merck Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table Merck Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table Merck Recent Development
  • Table Therapeutics Company Details
  • Table Therapeutics Description and Business Overview
  • Table Therapeutics Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Therapeutics Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table Therapeutics Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table Therapeutics Recent Development
  • Table Biocon Company Details
  • Table Biocon Description and Business Overview
  • Table Biocon Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Biocon Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table Biocon Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table Biocon Recent Development
  • Table Boehringer Ingelheim Company Details
  • Table Boehringer Ingelheim Description and Business Overview
  • Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales Growth Rate (2013-2018)
  • Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales Market Share in Global Market
  • Table Boehringer Ingelheim Recent Development
  • Table Celltrion Inc. Company Details
  • Table Coherus BioSciences Inc. Company Details
  • Table Zydus-Cadila Company Details
  • Table Genor BioPharma Company Details
  • Table Intas Pharmaceuticals Company Details
  • Table Novartis Company Details
  • Table Pfizer Company Details
  • Table Reliance Life Sciences Company Details
  • Figure Biosimilar Monoclonal Antibodies Value Chain
  • Table Biosimilar Monoclonal Antibodies Distributors List
  • Table Biosimilar Monoclonal Antibodies Customers List
  • Table Global Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Forecast 2018-2025 (Million US$)
  • Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Type 2018-2025
  • Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Application 2018-2025
  • Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Regions 2018-2025
  • Table Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Biosimilar Monoclonal Antibodies Sales Forecast by Countries 2018-2025 (K Units)
  • Table North America Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Countries 2018-2025
  • Table North America Biosimilar Monoclonal Antibodies Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Canada Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure MexicoBiosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Forecast by Countries 2018-2025 (K Units)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Biosimilar Monoclonal Antibodies Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure France Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure UK Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Italy Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Russia Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Forecast by Countries 2018-2025 (K Units)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Japan Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Korea Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure India Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Australia Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Indonesia Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Thailand Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Malaysia Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Philippines Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Figure Vietnam Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales Forecast by Countries 2018-2025 (K Units)
  • Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Biosimilar Monoclonal Antibodies Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Biosimilar Monoclonal Antibodies Sales Forecast 2018-2025 (K Units)
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2018-2025 (K Units)
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Biosimilar Monoclonal Antibodies Sales Growth Rate (2016-2025) (K Units)
  • Figure Egypt Biosimilar Monoclonal Antibodies Sales Growth Rate (2016-2025) (K Units)
  • Figure South Africa Biosimilar Monoclonal Antibodies Sales Growth Rate (2016-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top